| Karyopharm Therapeutics Inc. (KPTI) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Sep-30 | 2020-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 | ||||||
| Fiscal Period | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q3-FY2020 | Q2-FY2020 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | Q4-FY2013 | ||||||
| Price to Sales | 686.68x | .40x | .27x | 3.39x | .58x | .69x | .71x | 1.23x | .68x | 1.05x | 1.40x | 2.98x | 1.76x | 1.74x | 1.42x | 2.49x | 2.32x | 3.71x | 7.57x | 6.85x | 10.54x | 11.80x | 19.84x | 28.53x | 25.44x | 36.12x | 17.34x | 18.63x | 32.59x | 26.94x | 57.93x | 282.06x | 4,398.30x | ||||||||||||||||
| Price to Book | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.54x | 12.83x | 7.03x | 23.44x | 9.77x | 4.42x | 2.93x | 3.09x | 6.03x | 3.97x | 7.00x | 3.50x | 3.68x | ||||||||||||||||
| Price to Earnings | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||||||||||||
| Price to Unlevered FCF | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||||||
| Debt to Asset Ratio | 3.80x | 3.28x | 2.61x | 2.13x | 1.84x | 1.62x | 1.83x | 1.57x | 1.37x | 1.24x | 1.14x | 1.05x | 1.61x | 1.45x | 1.28x | 1.26x | 1.50x | 1.29x | 1.14x | .84x | .75x | .66x | .83x | .58x | .46x | .22x | .17x | .35x | .28x | .14x | .10x | .11x | .10x | .09x | .10x | .08x | .08x | .07x | .06x | .06x | .06x | .03x | .04x | .03x | .02x | ||||
| Current Ratio | 1.03x | .99x | 1.33x | 1.70x | 3.00x | 3.62x | 3.04x | 3.37x | 4.24x | 4.94x | 5.17x | 5.31x | 3.61x | 3.88x | 4.17x | 3.74x | 3.51x | 4.71x | 4.12x | 4.59x | 5.42x | 6.29x | 6.01x | 6.19x | 7.13x | 5.09x | 6.69x | 2.85x | 3.00x | 5.75x | 8.32x | 7.25x | 7.99x | 8.71x | 8.00x | 10.45x | 11.74x | 13.74x | 15.98x | 16.96x | 16.89x | 37.11x | 23.96x | 29.42x | 47.98x | ||||